Julie M. Vose, MD, MBA

Julie M. Vose, MD, MBA, is the Neumann M. and Mildred E. Harris Professor and chief of the Division of Oncology/Hematology at the University of Nebraska Medical Center in Omaha.

Dr Vose received her medical degree, completed her residency in Internal Medicine as chief resident, and completed a fellowship in Hematology and Oncology at the University of Nebraska Medical Center. In addition, she completed a sabbatical at Stanford University, and continued her education by obtaining an MBA in Health Administration from the University of Colorado Leeds School of Business.

Dr Vose has focused her career on translational research aimed at the improvement of therapy for non-Hodgkin lymphoma (NHL) and Hodgkin lymphoma by developing a focused translational research program evaluating novel therapies such as radiolabeled monoclonal antibodies, idiotype vaccine therapies, pathway-directed agents, stem cell transplantation, and chimeric antigen receptor T-cell therapy. Further, her funding record and extensive publications on NHL therapy and transplantation research have added substantially to the research and knowledge base for lymphoma therapy. As a result of her NHL research, Dr Vose has been recognized nationally and internationally through worldwide research awards and invited lectureships. She is a past president of the American Society of Clinical Oncology.